Dr. Daniel M. Tuvin, MD

Dr. Tuvin practices at Rochester General Hospital in Rochester, New York, part of Rochester Regional Health.

Dr. Tuvin's NPI, 1174785984, was assigned on July 2, 2008. Dr. Tuvin holds New York license 270651.

Dr. Tuvin's primary practice is Rochester General Hospital, at 1425 Portland Avenue, Rochester, NY 14621 in Monroe County. The practice phone is (585) 922-4000.

Dr. Tuvin's primary practice is Rochester General Hospital in Rochester, New York, part of Rochester Regional Health. The medical group on file is Rochester General Hospital. Dmand AI also links Dr. Tuvin to 1 more group practice or clinic and 1 medical group, each named with a free account.

Dmand AI tracks the electronic health record (EHR) system at each site where Dr. Tuvin practices, 2 sites in all. Vendor and product names are available with a free account.

Surgery is Dr. Tuvin's primary specialty in the NPI Registry, under taxonomy code 208600000X. Dmand AI has Dr. Tuvin's licenses on file in 2 states: New York and North Dakota.

CMS data shows 25 Medicare services from Dr. Tuvin across 2 procedure codes in 2024, all of them office visits, for 75 Medicare patients. Medicare paid $2,435 for them. Every service was in a facility, such as a hospital, rather than an office.

CMS counts 75 Medicare patients who saw Dr. Tuvin in 2024. The largest group is 65 to 74, with 39 patients. 69% of them have high cholesterol, and 63% have high blood pressure. Their average risk score is 2.02, where 1.00 is the Medicare average, so they are sicker than most Medicare patients.

Across all payers, Dmand AI patient panel data puts Dr. Tuvin's median patient age at 70, with 56% women.

In 2024, Dr. Tuvin wrote 29 Medicare Part D claims for 18 patients. 100% of them were for generic drugs. They cover 2 drugs, with $1,039 in total drug cost. In 2022, CMS named 99 claims across 3 drugs.

CMS publishes a Merit-based Incentive Payment System (MIPS) score of 97 out of 100 for Dr. Tuvin for performance year 2024, reported through an alternative payment model (APM). Dr. Tuvin accepts Medicare assignment, so Medicare's approved amount is taken as full payment. CMS counts 13 procedures of mastectomy by Dr. Tuvin, more than 68% of the clinicians it reports for that procedure.

Removal of skin lesions: 1 to 10 procedures (CMS shows small counts as a range)

Skin biopsy: 1 to 10 procedures (CMS shows small counts as a range)

Dmand AI links 9 papers to Dr. Tuvin, published from 2014 to 2025. The most frequent topics are Cell Line, Tumor, Antineoplastic Agents and Antineoplastic Combined Chemotherapy Protocols. Dr. Tuvin has published most often in ACS Appl Bio Mater. Dr. Tuvin's most frequent co-authors are Umut Sarpel, MD, Robert P. Sticca, MD and Miran Joel Blanchard, MD.

CMS Open Payments shows 33 general payments to Dr. Tuvin from 10 drug and device companies from 2016 to 2025. Education make up the largest share, 59% of the total. Intuitive Surgical, Inc. paid the most, $7,930.